Macrogen Europe logo — Committed to Sequencing Excellence

Macrogen Europe

Committed to Sequencing Excellence

Founded 2008 The Netherlands The Netherlands 71 employees Biotechnology, Health Care +3

General Information

Company Name Macrogen Europe
Founded Year 2008
Location The Netherlands The Netherlands
Employees 71
Industries Biotechnology, Health Care, Health and Wellness +2
Social

BounceWatch is an independent company data service, not affiliated with Macrogen Europe. To contact Macrogen Europe, visit macrogen-europe.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 22, 2026

Macrogen Europe will be participating in the CRC Days event in Paris on September 24th, with their NGS France team present.

About Macrogen Europe

Macrogen Europe is a biotechnology and healthcare company based in The Netherlands. Founded in 2008, the company is committed to sequencing excellence, as indicated by its slogan "Committed to Sequencing Excellence". Macrogen Europe specializes in providing fast and reliable Sanger sequencing, next generation sequencing (NGS), and bioinformatics services to scientists in Europe and Africa. With a focus on speed, accuracy, and scientific excellence, the company works closely with academic and clinical researchers, as well as the biotech industry, to leverage the potential of the genome. The company aims to realize the unlimited potential of genomics research and invites interested parties to reach out at [email protected]. Currently, there is no publicly available information about the company's last investment or its investors.

Taxonomy: Genomics, Sanger Sequencing, Next Generation Sequencing, Bioinformatics, Whole Exome Targeted, RNA Analysis, Single-cell Genomics, Epigenomics, Metagenomics, Research Partnerships, Biotech Industry, Scientific Excellence, Genome Sequencing, Academic Research

No funding data available for Macrogen Europe yet.

Macrogen Europe Alternatives & Competitors

Macrogen Europe vs
Phase Genomics
Phase Genomics United States

Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics

13 employees
Biotechnology, Clean Energy
Macrogen Europe vs
SeqLL
SeqLL United States

Quantitative RNA & Specialty DNA Sequencing Founded in 2013, SeqLL delivers a new breed of next-gen...

Venture round
7 employees
Biotechnology, Health Care
Macrogen Europe vs

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions

Series D
1011 employees
Biotechnology, Health Care

FAQ About Macrogen Europe

Committed to Sequencing Excellence
Macrogen Europe was founded in 2008.
Macrogen Europe is headquartered in The Netherlands.
Macrogen Europe operates in Biotechnology, Health Care, Health and Wellness, Life Sciences and Clean Energy. Its work centres on Genomics, Sanger Sequencing, Next Generation Sequencing and Bioinformatics.
Macrogen Europe has approximately 71 employees.
Top alternatives and competitors to Macrogen Europe include Phase Genomics, SeqLL, MEDGENOME, 3billion, SciGenom Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Macrogen Europe and Phase Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Macrogen Europe, https://bouncewatch.com/company/macrogen-europe, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes